In a recent study, prevalence of having two or more lifestyle risk factors 45.2 percent
Heterogeneity Found in Appropriate Use Criteria for Imaging of CAD
CMS-qualified AUC for coronary artery disease heterogeneous, sometimes conflict with respect to appropriateness
Canagliflozin Reduces Cardiorenal Biomarkers in T2D
Increase in biomarkers and multimarker panel linked to increased risk for primary cardiorenal outcome
Semaglutide Can Cut Prevalence of Obesity, CVD in Eligible U.S. Adults
Applying STEP 1 treatment would result in a 46.1 percent reduction in obesity prevalence and 17.8 percent relative risk reduction in CVD
Arterial Stiffness Progression Precedes Cardiac Damage in Teens
Increased systolic blood pressure and insulin resistance partially mediated relationship
Breastfeeding for at Least Six Months Aids Maternal Cardiovascular Factors
Findings similar for women who experienced a complication of pregnancy
Prolonged Direct Oral Anticoagulants Beneficial for Preventing Recurrent VTE
Findings seen among adults prescribed warfarin, DOACs beyond six months after acute venous thromboembolism
Incidence of New-Onset HTN Higher for COVID-19 Versus Influenza Patients
Hospitalized and nonhospitalized patients with COVID-19 more likely to develop persistent HTN than those with influenza
Prevalence of Recreational Drug Use 11 Percent in Cardiac ICUs
Those using recreational drugs have higher rate of in-hospital major adverse events
Six, 12 Weeks of Cytisinicline Efficacious for Smoking Cessation
Cytisinicline well tolerated with only 2.9 percent of participants discontinuing due to an adverse event